Monday, 16 April 2012 09:10
‘The treatment, which uses viruses carrying human DNA to direct the body’s natural defences against cancer cells, is the first prostate cancer vaccine ever to reach late stage “phase three” trials in Europe.
No vaccines have yet been approved in Britain to treat any type of cancer, and scientists believe it could not only double the survival rate of prostate cancer sufferers but give way to a new range of similar treatments for other tumour types.’
Read more: Prostate Cancer Vaccine Contains Genetically Modified DNA
Related posts:
Australia: Billions wiped off market in share bloodbath
Girl, 7, overdosed on travel sickness tablets on a school trip
Judge reveals name of ringleader of street gang who raped girl, 11, in McDonald's toilet
Peru Miners Trapped: Government Asks Mining Companies To Help Rescue Workers Trapped For Days
The ultimate street party! ONE MILLION Jubilee spectators line the banks of the Thames to celebrate ...
Indonesians protest fuel price hikes